• Home
  • Search Results
  • Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.

Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.

Molecular oncology (2014-05-13)
Changyou Li, Ann Marie Egloff, Malabika Sen, Jennifer R Grandis, Daniel E Johnson
ABSTRACT

Little is known regarding molecular markers in head and neck squamous cell carcinoma (HNSCC) that predict responsiveness to different therapeutic regimens or predict HNSCC progression. Mutations in procaspase-8 occur in 9% of HNSCC primary tumors, but the functional consequences of these mutations are poorly understood. In this study, we examined the impact of four, representative, HNSCC-associated procaspase-8 mutations on activation of the extrinsic apoptosis pathway, as well as cellular migration and invasion, and in vivo tumor growth. All four mutant proteins acted to potently inhibit activation of apoptosis following treatment with TRAIL or agonistic anti-Fas. In contrast to wild-type procaspase-8, the mutant proteins were not recruited to FADD following treatment with TRAIL or anti-Fas, but may be constitutively bound by FADD. Three of the four procaspase-8 mutants promoted enhanced cellular migration and invasion through matrigel, relative to that seen with the wild-type procaspase-8 protein. Procaspase-8 mutation also stimulated the growth of HNSCC xenograft tumors. These findings indicate that HNSCC-associated procaspase-8 mutations inhibit activation of the extrinsic apoptosis pathway and are likely to represent markers for resistance to therapeutic regimens incorporating death receptor activators. Moreover, procaspase-8 mutations may serve as markers of HNSCC tumor progression, as exemplified by enhanced migration, invasion, and tumor growth.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Anti-Fas Antibody (human, activating), clone CH11, clone CH11, Upstate®, from mouse
Sigma-Aldrich
Monoclonal Anti-PARP1 antibody produced in mouse, clone 3G4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-PARP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Caspase 3 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-PARP antibody produced in mouse, clone C-2-10, ascites fluid
Sigma-Aldrich
Anti-PARP1 antibody produced in rabbit, IgG fraction of antiserum
Sigma-Aldrich
Anti-FADD antibody, Mouse monoclonal, clone FD19, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-CD95 antibody produced in mouse, clone LT95, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-PARP1, (N-terminal) antibody produced in mouse, clone 2C7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-FAS antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-PARP (Cleaved-Asp214) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-PARP (Cleaved-Gly215) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-CASP3 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-Caspase-8 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-FAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-FADD (AB2) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-CASP3 antibody produced in rabbit, IgG fraction of antiserum
Sigma-Aldrich
Anti-FAS (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-FAS (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-CASP8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-FADD antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-CASP8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-CASP3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-FADD antibody produced in mouse, clone 3A12, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-FAS antibody produced in mouse, clone 2G3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-Caspase 3 antibody produced in mouse, clone 84803.111, purified immunoglobulin, lyophilized powder
Sigma-Aldrich
Anti-PARP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution